Molecular Imaging Study of Harmine/DMT: a Basic Research Approach

Conditions: Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine Interventions: Drug: N,N-dimethyltryptamine (DMT) + harmine; Drug: Placebo Sponsors: Insel Gruppe AG, University Hospital Bern; Psychiatric University Hospital, Zurich Recruiting

https://clinicaltrials.gov/study/NCT06252506

Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials